Flow estimation using an ultrasonically modulated contrast agent

• US 6,196,973 B1
• Filed: 09/30/1999
• Issued: 03/06/2001
• Est. Priority Date: 09/30/1999
• Status: Expired due to Term

• Current Assignee: Siemens Medical Solutions USA Incorporated (Siemens AG)
• Original Assignee: Siemens Medical Systems, Inc. (Siemens AG)
• Inventors: Slusher, Jeffrey, Lazenby, John C.
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): PATEL, MAULIN M
• Application Number:
  US09/410,169
• Time in Patent Office: 523 Days
• Field of Search: 600/437, 600/440, 600/441, 600/443, 600/447, 600/454, 600/458
• US Class Current: 600/458
• CPC Class Codes: A61B 8/06 Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: A61B 8/543 involving acquisition triggered by a physiological signal

Abstract

Reflectors such as microbubbles in a contrast agent introduced into a blood vessel of a patient are destroyed (or otherwise acoustically altered) using focused ultrasound at a modulation point according to an input modulation sequence. This creates “gaps” in the flowing contrast agent that are sensed at a downstream sensing point. The pattern of gaps is then matched in time with the input modulation sequence to determine a transit time for the gaps, which is also the flow velocity of the blood. The input modulation sequence creates at least two gaps, but may otherwise have any of several different forms, which include, among others, square-wave, maximal sequence, random binary patterns. Edge-detection and correlation techniques are used to match the input and sensed gap patterns. By triggering the input sequence off of a heart rate monitor, a flow velocity profile may also be calculated and displayed from one heart beat to the next. By also imaging the blood vessel and determining its cross-sectional area at at least one point, the invention is also able to provide a volumetric blood flow estimate.

Claims

1. A method for determining blood flow velocity in a blood vessel of a patient, comprising the following steps:

introducing a contrast agent into the blood vessel upstream from a modulation point, the contrast agent comprising a liquid carrier containing a concentration of ultrasound reflectors;

focusing a beam of ultrasound from a transducer onto the modulation point, the transducer having a high state, in which the ultrasonic beam significantly changes the ultrasound reflectivity of the insonified reflectors, and a low state, in which the reflectors pass the modulation point substantially unchanged;

energizing the transducer alternately between the high and low states according to a predetermined modulation sequence, thereby creating a pattern of a plurality of contrast agent gaps in which the reflectivity of the reflectors is changed;

from a sensing point in the blood vessel that is downstream from the modulation point, sensing an ultrasonic echo signal; and

determining a transit time of the contrast agent, and thus the blood flow velocity, between the modulation and sensing points, by calculating a time shift function of at least a portion of the modulation sequence and a corresponding portion of the echo signal.

2. A method as in claim 1, in which the steps of creating the pattern of contrast agent gaps, of sensing the ultrasonic echo signal, and of determining the transit time and blood flow velocity are repeated substantially continuously.

3. A method as in claim 1, in which the modulation sequence is a square-wave signal.

4. A method as in claim 1, in which the modulation sequence is a maximal sequence.

5. A method as in claim 1, in which the modulation sequence is a random binary sequence.

6. A method as in claim 1, in which the step of determining the transit time comprises the following sub-steps:

determining a time of passage of the at least one gap edge in the echo signal, a gap edge being a transition in the contract agent between a region having a relatively high reflector concentration and a region having a relatively low reflector concentration; and

determining the transit time of the contrast agent by calculating the time difference between the time of passage of the gap edge and a corresponding state transition in the modulation sequence.

7. A method as in claim 1, in which the step of determining the transit time of the contrast agent comprises correlating the sensed echo signal and the modulation sequence.

8. A method as in claim 1, further including the following steps:

sensing the heart beats of the patient; and

calculating and displaying updates of the blood flow velocity as a function of time from one heart beat to the next.

9. A method as in claim 1, further including the following steps:

estimating a cross-sectional area of the blood vessel at at least one point in the blood vessel located from the modulation point to the sensing point, inclusive; and

calculating an estimate of volumetric blood flow in the blood vessel as a function of the product of the estimated cross-sectional area and the blood flow velocity.

10. A system for determining blood flow velocity in a blood vessel of a patient, into which blood vessel a contrast agent has been introduced, the contrast agent comprising a liquid carrier containing a concentration of ultrasound reflectors;

comprising;

a transducer focusing a beam of ultrasound into the blood vessel at a modulation point that lies downstream from where the contrast agent has been introduced, the transducer having a high state, in which the ultrasonic beam significantly changes the ultrasound reflectivity of the insonified reflectors, and a low state, in which the reflectors pass the modulation point substantially unchanged;

transmission control means for energizing the transducer alternately between the high and low states according to a predetermined modulation sequence, thereby creating a pattern of a plurality of contrast agent gaps in which the concentration of reflectors is reduced;

echo sensing means for sensing an ultrasonic echo signal from a sensing point in the blood vessel that is downstream from the modulation point; and

processing means for determining a transit time of the contrast agent, and thus the blood flow velocity, between the modulation and sensing points, by calculating a time shift function of at least a portion of the modulation sequence and a corresponding portion of the echo signal.

11. A system as in claim 10, further including:

a heart beat monitor; and

a display;

the processing means being further provided for calculating and displaying updates of the blood flow velocity as a function of time from one monitored heart beat to the next.

12. A system as in claim 10, further including area estimation means for estimating a cross-sectional area of the blood vessel at at least one point in the blood vessel located from the modulation point to the sensing point, inclusive;

the processing means being further provided for calculating an estimate of volumetric blood flow in the blood vessel as a function of the product between the estimated cross-sectional area and the blood flow velocity.